Home›Companies›Biotech & Pharma›Apothewell

Apothewell, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 15, 2023·Suggest an edit

About Apothewell

Apothewell is a private company based in Little Rock, Arkansas, incorporated in 2021 in Arkansas. It has reported $154,000 raised in five offerings on Form D since August 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 1, 2023Dec 15, 2023$11,000of $200K target1$11,000Offering is in the form of SAFE Agreements, which give the holder the right and option to purchase preferred stock (when issued) using previously paid funds.Rule 506(b)Form D ↗
Sep 28, 2023Oct 13, 2023$45,000of $75,000 target9$5,000Equity, Debt, Offering is in the form of SAFE Agreements, which give the holder the right and option to purchase preferred stock (when issued) using previously paid funds.Rule 506(b)Form D ↗
Mar 13, 2023Mar 28, 2023$40,000of $110K target1$40,000Equity, Debt, SAFE Agreements which give the holder the right to purchase using the previously paid funds when the Company issues preferred stock.Rule 506(b)Form D ↗
Aug 3, 2022Aug 11, 2022$8,000target not set1$8,000EquityRule 506(b)Form D ↗
Jul 21, 2021Aug 4, 2021$50,000target not set10$5,000EquityRule 506(b)Form D ↗
Total, five offerings$154,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Apothewell's Form D filed Dec 15, 2023.

DS
Daniel Sharp
Executive officer and director

Sources

  1. SECApothewell, Inc. filing history